Jeff Weiss

Writer & Commentator, Chief Engagement Officer
DF Medical Ventures
Biography
Jeff has recently been appointed Chief Engagement Officer for DF Medical Ventures, which seeks to market a medicinal smoking cessation product.
Jeff Weiss was Chief Engagement Officer, General Counsel, and Interim President of NJOY, the third largest e-cigarette company in the United States. An NJOY lawsuit against FDA, culminating in a 2011 D.C. Circuit decision in the company’s favor, paved the way for FDA regulation of non-medicinal nicotine products. In 2022, NJOY became the first independent vaping company to secure PMTA authorizations from FDA. Weiss’s tenure with NJOY ended with the company’s sale to Altria in June 2023. Weiss has a Master’s Degree in Biotechnology from Johns Hopkins University, a law degree from Arizona State University College of Law, and an LLM in International and Comparative Law from Georgetown University Law Center.
Speaker in
- Industry’s attitude toward potential reforms of FDA’s nicotine and tobacco policy
May 19 2025 11:20 am - Panel Discussion and Q&A
May 19 2025 12:05 pm
« Back